You are here

  • Home
  • Archive
  • Volume 77, Issue 4
  • Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study

Article info

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study

Authors

  • Lene Dreyer Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte University Hospital, Hellerup, Denmark Department of Rheumatology, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark PubMed articlesGoogle scholar articles
  • René L Cordtz Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte University Hospital, Hellerup, Denmark Department of Rheumatology, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark PubMed articlesGoogle scholar articles
  • Inger Marie J Hansen Department of Clinical Medicine, University of Southern Denmark, Odense, Denmark Department of Internal Medicine, Section of Rheumatology OUH, Svendborg Hospital, Svendborg, Denmark PubMed articlesGoogle scholar articles
  • Lars Erik Kristensen Department of Rheumatology, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark PubMed articlesGoogle scholar articles
  • Merete L Hetland Center for Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research, Rigshospitalet, Glostrup, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark DANBIO Registry, Rigshospitalet, Glostrup, Denmark PubMed articlesGoogle scholar articles
  • Lene Mellemkjaer Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lene Dreyer, Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte University Hospital, Hellerup 2900, Denmark; lene.dreyer{at}regionh.dk
View Full Text

Citation

Dreyer L, Cordtz RL, Hansen IMJ, et al
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study
Annals of the Rheumatic Diseases 2018;77:510-514.

Publication history

  • Received July 17, 2017
  • Revised October 30, 2017
  • Accepted November 20, 2017
  • First published December 7, 2017.
Online issue publication 
October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.